Crossmark

Clinical value of serum biomarkers, magnetic resonance imaging risk scoring, and malignancy risk indices in distinguishing benign and malignant ovarian masses: an observational study

Crossref DOI link: https://doi.org/10.1007/s10552-025-02088-y

Published Online: 2025-12-24

Published Print: 2026-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Kumar, Naina https://orcid.org/0000-0002-5970-6935
Mangla, Mishu

Roy, Subhrajyoti

Setty, Aparna

Veldi, Srujana

Rathod, Pooja T.
License Information

Text and Data Mining valid from 2025-12-24

Version of Record valid from 2025-12-24
More Information

Article History

Received: 16 September 2025

Accepted: 22 November 2025

First Online: 24 December 2025

Declarations

:

: Authors have no conflicts of interest to disclose.

: This study was approved by the Institutional Ethical Committee (AIIMS/BBN/IEC/July/2023/295).

: The study was conducted after informed written consent from the patient.

Document is current

Any future updates will be listed below